0001209191-15-064903.txt : 20150810 0001209191-15-064903.hdr.sgml : 20150810 20150810162940 ACCESSION NUMBER: 0001209191-15-064903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150806 FILED AS OF DATE: 20150810 DATE AS OF CHANGE: 20150810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levy Richard S CENTRAL INDEX KEY: 0001454983 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 151041107 MAIL ADDRESS: STREET 1: EXPERIMENTAL STATION STREET 2: ROUTE 141 AND HENRY CLAY RD CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-06 0 0000879169 INCYTE CORP INCY 0001454983 Levy Richard S 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Chief Drug Dev Officer Common Stock 2015-08-06 4 M 0 3936 18.32 A 25163 D Common Stock 2015-08-06 4 S 0 3936 111.95 D 21227 D Non-Qualified Stock Option (right to buy) 18.32 2015-08-06 4 M 0 3936 0.00 D 2020-02-08 Common Stock 3936 22560 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Eric Siegel, Attorney-In-Fact 2015-08-10